Who owns EFFECTOR THERAPEUTICS INC?
- Ticker: EFTRW
- CUSIP Number: 28202v116
Tip: Access positions for across all investors
Analyze quarterly positions in Effector Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Effector Therapeutics stock
Who bought or sold EFFECTOR THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Aristeia Capital | 1.5M | $158k | 0% | Dec 2023 |
|
| Goldman Sachs Group | 631k | $46k | 0% | Dec 2023 |
|
| Whitebox Advisors | 298k | $44k | 0% | Dec 2023 |
|
| MMCAP International Inc. SPC | 146k | $22k | 0% | Dec 2023 |
|
| Parallel Advisors | 64k | $4.6k | 0% | Dec 2023 |
|
| Millennium Management | 56k | $8.3k | 0% | Dec 2023 |
|
| III Capital Management | 42k | $4.4k | 0% | Dec 2023 |
|
| Tenor Capital Management | 33k | $4.9M | 0% | Dec 2023 |
|
| Sea Otter Advisors | 25k | $3.7k | 0% | Dec 2023 |
|
| Wolverine Asset Management | 18k | $2.6k | -5% | Dec 2023 |
|
| UBS Group | 1.4k | $102.961200 | 100% | Dec 2023 |
|
| Pineridge Advisors | 33.00 | $1.999800 | 100% | Dec 2023 |
|